CN102680687A - 蛋白质terf1在制备诊断胃癌的试剂中的应用及诊断试剂盒 - Google Patents
蛋白质terf1在制备诊断胃癌的试剂中的应用及诊断试剂盒 Download PDFInfo
- Publication number
- CN102680687A CN102680687A CN2012101488884A CN201210148888A CN102680687A CN 102680687 A CN102680687 A CN 102680687A CN 2012101488884 A CN2012101488884 A CN 2012101488884A CN 201210148888 A CN201210148888 A CN 201210148888A CN 102680687 A CN102680687 A CN 102680687A
- Authority
- CN
- China
- Prior art keywords
- terf1
- solution
- protein
- gastric cancer
- diagnostic kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000005718 Stomach Neoplasms Diseases 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 238000009007 Diagnostic Kit Methods 0.000 title claims abstract description 16
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 14
- 101710170289 Telomeric repeat-binding factor 1 Proteins 0.000 title abstract description 31
- 102100036497 Telomeric repeat-binding factor 1 Human genes 0.000 title abstract description 31
- 210000002966 serum Anatomy 0.000 claims abstract description 36
- 108090000790 Enzymes Proteins 0.000 claims abstract description 14
- 102000004190 Enzymes Human genes 0.000 claims abstract description 14
- 239000000427 antigen Substances 0.000 claims abstract description 13
- 102000036639 antigens Human genes 0.000 claims abstract description 13
- 108091007433 antigens Proteins 0.000 claims abstract description 13
- 239000000758 substrate Substances 0.000 claims abstract description 13
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims abstract description 12
- 238000002965 ELISA Methods 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 9
- 230000000694 effects Effects 0.000 claims abstract description 7
- 108090000144 Human Proteins Proteins 0.000 claims abstract description 6
- 102000003839 Human Proteins Human genes 0.000 claims abstract description 6
- 239000002253 acid Substances 0.000 claims abstract description 5
- 238000005406 washing Methods 0.000 claims abstract description 4
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 3
- 239000007790 solid phase Substances 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 40
- 206010017758 gastric cancer Diseases 0.000 claims description 29
- 201000011549 stomach cancer Diseases 0.000 claims description 28
- 238000003745 diagnosis Methods 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 14
- 238000013016 damping Methods 0.000 claims description 13
- 239000012530 fluid Substances 0.000 claims description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 12
- 102000007315 Telomeric Repeat Binding Protein 1 Human genes 0.000 claims description 10
- 108010033711 Telomeric Repeat Binding Protein 1 Proteins 0.000 claims description 10
- 239000011780 sodium chloride Substances 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 9
- 239000000872 buffer Substances 0.000 claims description 8
- 238000007865 diluting Methods 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 6
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 claims description 5
- VOZKAJLKRJDJLL-UHFFFAOYSA-N 2,4-diaminotoluene Chemical compound CC1=CC=C(N)C=C1N VOZKAJLKRJDJLL-UHFFFAOYSA-N 0.000 claims description 4
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 230000002018 overexpression Effects 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 2
- 238000001261 affinity purification Methods 0.000 claims description 2
- 230000002421 anti-septic effect Effects 0.000 claims description 2
- 229940098773 bovine serum albumin Drugs 0.000 claims description 2
- 239000007853 buffer solution Substances 0.000 claims description 2
- 229960002163 hydrogen peroxide Drugs 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 239000001632 sodium acetate Substances 0.000 claims description 2
- 235000017281 sodium acetate Nutrition 0.000 claims description 2
- 238000013399 early diagnosis Methods 0.000 abstract description 9
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 2
- 239000011148 porous material Substances 0.000 abstract 1
- 201000000498 stomach carcinoma Diseases 0.000 description 27
- 239000000523 sample Substances 0.000 description 22
- 206010028980 Neoplasm Diseases 0.000 description 15
- 230000014509 gene expression Effects 0.000 description 14
- 201000011510 cancer Diseases 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- 239000000090 biomarker Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 108010017842 Telomerase Proteins 0.000 description 4
- 208000010749 gastric carcinoma Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000004393 prognosis Methods 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108700020796 Oncogene Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000011902 gastrointestinal surgery Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 108091035539 telomere Proteins 0.000 description 2
- 102000055501 telomere Human genes 0.000 description 2
- 210000003411 telomere Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000000439 tumor marker Substances 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 206010000830 Acute leukaemia Diseases 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000714144 Homo sapiens Telomeric repeat-binding factor 1 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 241000551546 Minerva Species 0.000 description 1
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- 108010047956 Nucleosomes Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 108010038599 Telomere-Binding Proteins Proteins 0.000 description 1
- 102000010823 Telomere-Binding Proteins Human genes 0.000 description 1
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000001623 nucleosome Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000005748 tumor development Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210148888.4A CN102680687B (zh) | 2012-05-14 | 2012-05-14 | 蛋白质terf1在制备诊断胃癌的试剂中的应用及诊断试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210148888.4A CN102680687B (zh) | 2012-05-14 | 2012-05-14 | 蛋白质terf1在制备诊断胃癌的试剂中的应用及诊断试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102680687A true CN102680687A (zh) | 2012-09-19 |
CN102680687B CN102680687B (zh) | 2014-12-24 |
Family
ID=46812930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210148888.4A Active CN102680687B (zh) | 2012-05-14 | 2012-05-14 | 蛋白质terf1在制备诊断胃癌的试剂中的应用及诊断试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102680687B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110261618A (zh) * | 2019-06-14 | 2019-09-20 | 上海四核生物科技有限公司 | Sprr4蛋白作为胃癌血清生物标志物的应用及其试剂盒 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101493463A (zh) * | 2008-01-24 | 2009-07-29 | 上海交通大学医学院附属瑞金医院 | 胃癌诊断试剂及其用途 |
WO2010028658A1 (en) * | 2008-09-15 | 2010-03-18 | Herlev Hospital, Region Hovedstaden | Ykl-40 as a marker for gastrointestinal cancers |
-
2012
- 2012-05-14 CN CN201210148888.4A patent/CN102680687B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101493463A (zh) * | 2008-01-24 | 2009-07-29 | 上海交通大学医学院附属瑞金医院 | 胃癌诊断试剂及其用途 |
WO2010028658A1 (en) * | 2008-09-15 | 2010-03-18 | Herlev Hospital, Region Hovedstaden | Ykl-40 as a marker for gastrointestinal cancers |
Non-Patent Citations (2)
Title |
---|
江红 等: "人端粒结合蛋白TRF1的克隆、表达和抗体制备", 《生物工程学报》, vol. 20, no. 1, 31 January 2004 (2004-01-31) * |
邹媚 等: "端粒重复序列结合因子1蛋白在胃癌组织中的表达及意义", 《中国现代医药杂志》, vol. 10, no. 10, 31 October 2008 (2008-10-31) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110261618A (zh) * | 2019-06-14 | 2019-09-20 | 上海四核生物科技有限公司 | Sprr4蛋白作为胃癌血清生物标志物的应用及其试剂盒 |
CN110261618B (zh) * | 2019-06-14 | 2021-08-31 | 上海四核生物科技有限公司 | Sprr4蛋白作为胃癌血清生物标志物的应用及其试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN102680687B (zh) | 2014-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102680709B (zh) | 诊断试剂盒及ccdc49在制备胃癌早期诊断试剂中的应用 | |
WO2017107974A1 (zh) | 血清psmd4蛋白的检测试剂盒及其检测方法与应用 | |
CN103547923B (zh) | 乳腺癌的生物标记 | |
CN106053812B (zh) | 一种用于肝癌早期筛查和诊断的多种自身抗体联合检测elisa试剂盒 | |
Chen et al. | Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting | |
CN111273012B (zh) | 一种血清自身抗体联合检测的方法 | |
CN102680706B (zh) | 蛋白质ctsf在制备诊断胃癌的试剂中的应用及诊断试剂盒 | |
Nyström et al. | Type IV collagen as a tumour marker for colorectal liver metastases | |
CN110187109A (zh) | 一种用于贲门腺癌早期筛查的自身抗体联合检测elisa试剂盒 | |
WO2016029117A1 (en) | Methods for the early detection of colorectal cancer | |
CN107462725B (zh) | 抗FNDC4的IgG抗体作为胃癌血清标志物的应用及其试剂盒 | |
CN109116023B (zh) | 一种肺癌标志物抗-mmp12自身抗体及其应用 | |
CN102680708B (zh) | 诊断试剂盒及rnf19在制备胃癌早期诊断试剂中的应用 | |
CN110187111A (zh) | 一种用于早期贲门癌筛查elisa试剂盒 | |
CN102680687A (zh) | 蛋白质terf1在制备诊断胃癌的试剂中的应用及诊断试剂盒 | |
CN115372616B (zh) | 胃癌相关的生物标志物及其应用 | |
CN107144688B (zh) | Cd19阳性外泌体作为分子标记在制备肿瘤诊断试剂盒中的应用及试剂盒 | |
CN110261618B (zh) | Sprr4蛋白作为胃癌血清生物标志物的应用及其试剂盒 | |
CN114994306A (zh) | 一种蛋白质pknox1在制备诊断酒精性心肌病的试剂中的应用及诊断试剂盒 | |
CN110261611B (zh) | Znf709蛋白作为胃癌血清生物标志物的应用及其试剂盒 | |
CN102798722B (zh) | 蛋白质nt5e在制备诊断胃癌的试剂中的应用及诊断试剂盒 | |
CN102680707B (zh) | 蛋白质cops2在制备诊断胃癌的试剂中的应用及诊断试剂盒 | |
CN102680688B (zh) | 诊断试剂盒及bfar在制备胃癌早期诊断试剂中的应用 | |
CN113671180A (zh) | Paip1自身抗体在食管鳞癌辅助诊断中的应用 | |
CN102971630A (zh) | 非酒精性脂肪性肝炎检测和/或鉴别用标记物、检测和/或鉴别非酒精性脂肪性肝炎的方法及用于它们的试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120919 Assignee: CHENGDU CAPITALBIO NEW VIEW DIAGNOSTIC TECHNOLOGY Co.,Ltd. Assignor: Shanghai Jiao Tong University Contract record no.: 2016990000394 Denomination of invention: Application of protein TERF1 (telomeric repeat binding factor 1) to preparation of reagent for diagnosing gastric cancers and diagnostic kit Granted publication date: 20141224 License type: Exclusive License Record date: 20160913 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: CHENGDU CAPITALBIO NEW VIEW DIAGNOSTIC TECHNOLOGY Co.,Ltd. Assignor: SHANGHAI JIAO TONG University Contract record no.: 2016990000394 Date of cancellation: 20231229 |
|
EC01 | Cancellation of recordation of patent licensing contract |